KIMBERLY MILLER: Open Payments
NPI 1548814684 · FORT MYERS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,102 in 49 payments from 17 companies in 2025. Trend: 2023 $137 · 2024 $424 · 2025 $1,102
Food & beverage: $1,102
| Company | Payments | Amount |
|---|---|---|
| CVRx, Inc. | 12 | $213 |
| E.R. Squibb & Sons, L.L.C. | 6 | $173 |
| Novartis Pharmaceuticals Corporation | 6 | $138 |
| Alnylam Pharmaceuticals Inc. | 3 | $99 |
| Novo Nordisk Inc | 3 | $82 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $73 |
| Amgen Inc. | 3 | $61 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $39 |
| PFIZER INC. | 2 | $35 |
| AstraZeneca Pharmaceuticals LP | 2 | $32 |
Products named: Barostim Neo System, LEQVIO, CAMZYOS, ONPATTRO, ELIQUIS, Wegovy, Kerendia, REPATHA.
Industry payments across FL — which companies pay providers there.
